文献
J-GLOBAL ID:202202214098455257
整理番号:22A0479803
ベースライン尿酸値および定常状態ファビピラビル濃度は,COVID-19患者における高尿酸血症の発生と関連する【JST・京大機械翻訳】
Baseline uric acid levels and steady-state favipiravir concentrations are associated with occurrence of hyperuricemia among COVID-19 patients
著者 (8件):
Koseki Takenao
(Department of Clinical Pharmacy, Fujita Health University School of Medicine, Toyoake, Aichi, Japan)
,
Nakajima Kazuki
(Center for Joint Research Facilities Support, Research Promotion and Support Headquarters, Fujita Health University, Toyoake, Aichi, Japan)
,
Iwasaki Hitoshi
(Department of Clinical Pharmacy, Fujita Health University School of Medicine, Toyoake, Aichi, Japan)
,
Yamada Shigeki
(Department of Clinical Pharmacy, Fujita Health University School of Medicine, Toyoake, Aichi, Japan)
,
Takahashi Kazuo
(Department of Biomedical Molecular Sciences, Fujita Health University School of Medicine, Toyoake, Aichi, Japan)
,
Doi Yohei
(Departments of Microbiology and Infectious Diseases, Fujita Health University School of Medicine, Toyoake, Aichi, Japan)
,
Doi Yohei
(Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA)
,
Mizuno Tomohiro
(Department of Clinical Pharmacy, Fujita Health University School of Medicine, Toyoake, Aichi, Japan)
資料名:
International Journal of Infectious Diseases
(International Journal of Infectious Diseases)
巻:
115
ページ:
218-223
発行年:
2022年
JST資料番号:
W3271A
ISSN:
1201-9712
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)